121
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Letrozole
Part A Monitor standard of care letrozole use for 28 days; measure blood levels of estrogens and vitamin D at start and end of period. Part B In overweight/obese participants who completed Part A, provide a double dose of letrozole and monitor use for 28 days; measure blood levels of estrogens and vitamin D at start and end of period.
Princess Margaret Hospital, Toronto
Mount Sinai Hospital, Toronto
Women's College Hospital, Toronto
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
OTHER